Spyre Therapeutics
SYRE
#4929
Rank
โ‚ฌ1.34 B
Marketcap
22,86ย โ‚ฌ
Share price
3.16%
Change (1 day)
38.71%
Change (1 year)

Spyre Therapeutics (SYRE) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ0.39 Billion

According to Spyre Therapeutics's latest financial reports the company has โ‚ฌ0.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spyre Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ0.30 B490.93%
2022-12-31โ‚ฌ51.93 M-36.84%
2021-12-31โ‚ฌ82.23 M-30.85%
2020-12-31โ‚ฌ0.11 B85.16%
2019-12-31โ‚ฌ64.22 M-1.39%
2018-12-31โ‚ฌ65.13 M55.37%
2017-12-31โ‚ฌ41.92 M-30.56%
2016-12-31โ‚ฌ60.37 M99.66%
2015-12-31โ‚ฌ30.23 M1305.79%
2014-12-31โ‚ฌ2.15 M-35.38%
2013-12-31โ‚ฌ3.32 M